Cocrystal Pharma (COCP) Prepaid Assets (2010 - 2026)
Cocrystal Pharma (COCP) reported Prepaid Assets of $418000.0 for Q1 2026, up 8.57% on a YoY basis from $385000.0 in Q1 2025, and up 27.44% sequentially from $328000.0 in Q4 2025.
Cocrystal Pharma (COCP) Prepaid Assets (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 17 years of Prepaid Assets data on file, last reported at $418000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 8.57% year-over-year to $418000.0; the trailing twelve-month figure through Mar 2026 stood at $418000.0 (up 8.57% YoY), and the FY2025 full-year result was $328000.0, down 23.72% from the prior year.
- Prepaid Assets rose to $418000.0 in Q1 2026, from $328000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.8 million in Q3 2022 to a low of $282000.0 in Q2 2025.
- A 5-year average of $1.1 million and a median of $509000.0 in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 322.13% in 2023 and plunged 82.28% in 2024, its largest moves.
- Tracing COCP's Prepaid Assets over 5 years: stood at $2.2 million in 2022, then declined by 20.95% to $1.8 million in 2023, then slumped by 75.75% to $430000.0 in 2024, then decreased by 23.72% to $328000.0 in 2025, then grew by 27.44% to $418000.0 in 2026.
- Business Quant data shows COCP's Prepaid Assets at $418000.0 in Q1 2026, $328000.0 in Q4 2025, and $465000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 418,000.00 |
| Dec 31, 2025 | 328,000.00 |
| Sep 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 282,000.00 |
| Mar 31, 2025 | 385,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 509,000.00 |
| Jun 30, 2024 | 365,000.00 |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | 2.77 Mn |
| Jun 30, 2022 | 488,000.00 |
| Mar 31, 2022 | 560,000.00 |
| Dec 31, 2021 | 568,000.00 |
| Sep 30, 2021 | 747,000.00 |
| Jun 30, 2021 | 225,000.00 |